# Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

> **NCT02828319** · PHASE3 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 39 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Z-213

## Key facts

- **NCT ID:** NCT02828319
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828319, "Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02828319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*